A Nobel prize-winning economist on what it might take to get our economy growing again.

Chloroquine and hydroxycloroquine got the Food and Drug Administration's go-ahead to be put in the nation's strategic storehouses. But the drugs haven't been approved to treat coronavirus patients.

Jay Carney, Amazon's senior VP of global corporate affairs, describes the company's growing role during the coronavirus outbreak and how it is trying to keep its workers safe.

Nick Clegg, vice president of global affairs and communications, says the company will work to remove coronavirus-related information that has the potential to cause physical harm.

NPR is looking to hear from people who lost their jobs or income during the coronavirus pandemic and who are trying to get help from mortgage companies or other lenders.

Jobless claims hit an all-time record, with 10 million filed in the last two weeks. With so many people filing, there are glitches. Experts offer suggestions on how to get through.

By renouncing the special status, Gilead Sciences lets go of tax breaks, fee waivers and seven years without generic competition for remdesivir, its experimental COVID-19 treatment.

Gilead Science's remdesivir, an antiviral medicine being tested for treatment of COVID-19, would get a seven-year monopoly if approved by the Food and Drug Administration.

Airlines say they will likely have to lay off thousands of workers if Congress can't pass a coronavirus economic relief package soon. Amtrak, bus lines and subways are suffering, too.

When we shop in a store, we're used to having options. But in a digital economy controlled by tech monopolies, choice isn't built in. Margrethe Vestager is on a mission to change that.